Cellular Immunity Confers Transient Protection in Experimental Buruli Ulcer following BCG or Mycolactone-Negative Mycobacterium ulcerans Vaccination

Buruli ulcer

(2011) Thorbjorg Einarsdottir et al.   Human vaccines & immunotherapeutics

BCG-Mediated Protection against Mycobacterium ulcerans Infection in the Mouse

(2011) Paul J. Converse et al.   PLoS Neglected Tropical Diseases

MycobacteriumulceransTriggers T-Cell Immunity followed by Local and Regional but Not Systemic Immunosuppression

(2010) Alexandra G. Fraga et al.   INFECTION AND IMMUNITY

Cell-Mediated Immune Responses in Tuberculosis

(2009) Andrea M. Cooper   Annual Review of Immunology

IFN- -Dependent Activation of Macrophages during Experimental Infections by Mycobacterium ulcerans Is Impaired by the Toxin Mycolactone

(2009) E. Torrado et al.   JOURNAL OF IMMUNOLOGY

Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer

(2009) Manuel T Silva et al.   LANCET INFECTIOUS DISEASES

Buruli ulcer disease: prospects for a vaccine

(2009) Kris Huygen et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

Excision of Pre-Ulcerative Forms of Buruli Ulcer Disease: A Curative Treatment?

(2008) K.-H. Herbinger et al.   INFECTION

Improved Protective Efficacy of a Species-Specific DNA Vaccine Encoding Mycolyl-Transferase Ag85A from Mycobacterium ulcerans by Homologous Protein Boosting

(2008) Audrey Tanghe et al.   PLoS Neglected Tropical Diseases